🇺🇸 FDA
Patent

US 6706754

Reversed amidines and methods of using for treating, preventing, or inhibiting leishmaniasis

expired A61KA61K31/341A61K31/381

Quick answer

US patent 6706754 (Reversed amidines and methods of using for treating, preventing, or inhibiting leishmaniasis) held by The United States of America as represented by the Secretary of the Army expires Mon Mar 11 2024 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The United States of America as represented by the Secretary of the Army
Grant date
Tue Mar 16 2004 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 11 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
29
CPC classes
A61K, A61K31/341, A61K31/381, A61K31/4184, A61K31/444